Tennessee Oncology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Tennessee Oncology
Jun 23, 2024, 10:54 |
Blog
Julie Gralow: The value of participating in ASCO certified patient-centered care quality initiative
Julie Gralow shared a post by ASCO, on X: "Nice piece demonstrating the value of participating…
Jun 23, 2024, 04:12 |
Insight
Importance of quality care delivery in a new op-ed from Physician's Weekly - ASCO
American Society of Clinical Oncology (ASCO) shared a post on LinkedIn: “In a new op-ed…
May 30, 2024, 10:18 |
Blog
It’s an uplifting day for cancer survivors! - .406 Ventures
.406 Ventures shared on LinkedIn: . "It’s an uplifting day for cancer survivors!…
May 2, 2024, 12:01 |
Blog
Ramy Sedhom: In lockstep with the ASCO Presidential Theme - Palliative Care is on the stage as a plenary at this year's Annual Meeting
Ramy Sedhom, Clinical Director of Palliative Care at Penn Medicine Princeton Health, shared a post…
Mar 10, 2024, 21:03 |
Blog
Vivek Subbiah: Research should be standard-of-care and standard-of-care should be research
Vivek Subbiah recently posted on LinkedIn: "Yes! “Research should be standard-of-care and standard-of-care should be research”!!!…
Feb 7, 2024, 19:11 |
Blog
Samyukta Mullangi: In 2023, CMS issued new guidance that betrays a deep degree of misinformation about the modern cancer therapeutic landscape
Samyukta Mullangi, Medical Oncologist at Tennessee Oncology and Medical Director at Thyme Care, shared a…
Dec 25, 2023, 16:22 |
Blog
Stephen Schleicher: Our final Oncology Onward
Stephen Schleicher, Medical Oncologist and Chief Medical Officer at Tennessee Oncology, shared on LinkedIn: "Check…
Nov 21, 2023, 14:24 |
Blog
Stephen Schleicher: A big few months for Tennessee Oncology
Stephen Schleicher, Medical Oncologist and Chief Medical Officer at Tennessee Oncology, shared a post on LinkedIn:…
All:
8
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube